Clinical Trials on PYRAX
Clinical trials are slow, costly, and dogged by data-integrity and enrollment problems, while participant privacy and site payments add operational drag. PYRAX brings tamper-evident data capture, milestone-based escrow for site and CRO payments, and PYRAX Compute compute-to-data so sponsors can analyze patient-level data across sites without ever centralizing it.
The market
Source: Grand View Research, 2024. Figures are indicative and provided for context.
What's broken today
How PYRAX transforms it
Concrete network elements mapped to this business.
Tamper-evident data capture
Every case-report-form entry is committed on-chain, making source data alteration detectable and giving regulators a verifiable audit trail.
On-chain escrow for milestone payments
Site, investigator, and CRO payments release automatically from escrow when enrollment or visit milestones are cryptographically verified.
PYRAX Compute compute-to-data analytics
Sponsors train and run statistical models across sites' private patient data in place, receiving verifiable results without any site exporting identifiable records.
Shielded-by-default participant privacy
Participant identities and PHI remain off-chain as commitments, so enrollment and outcomes are auditable while individuals stay unidentifiable.
Viewing keys for monitors and IRBs
CRAs, IRBs, and regulators receive scoped read-only keys to verify data integrity and consent without broad access to the patient population.
Buildathon: dApp ideas
Ship-ready concepts for clinical trials on PYRAX.
TrialLedger
01eCRF capture where each entry is a commitment, giving 21 CFR Part 11-grade tamper evidence.
MilestonePay
02Escrow contract auto-releasing site and CRO payments on verified enrollment and visit milestones.
CohortAI
03PYRAX Compute cross-site model training on private patient data with verifiable results and zero data movement.
eConsentChain
04Digital informed-consent with revocable, shielded participant consent receipts.
MonitorKey
05Remote-monitoring portal for CRAs and IRBs reading integrity metrics via scoped viewing keys.
RecruitMatch
06Privacy-preserving eligibility matcher that screens patients against protocols using ZK proofs, never exposing identities.
AdverseWatch
07Tamper-evident adverse-event reporting with instant-finality timestamps for pharmacovigilance.
TrialProof
08Public results-registry publishing commitment proofs of primary endpoints to combat selective reporting.